Anne Tybjaerg-Hansen Articles
Genetics of Lp(a) and CVD
Reports from the 9th Closed Expert Meeting of the PCSK9 Education and Research Forum Professor Anne Tybjærg-Hansen
read more »Posted on 3 December 2018 |
Posted by Anne Tybjaerg-Hansen | Posted in Webcasts,
9th Closed Scientific Expert Meeting of the Editorial Board
Loss of function mutations in PCSK9: the trigger for therapeutic development
Studies of mutations of PCSK9 function have identified a new therapeutic target for reducing very high levels of low density lipoprotein cholesterol (LDL-C). Professor Anne Tybjaerg-Hansen describes this opportunity.
read more »
Mechanistic insights from PCSK9 LOF mutations
Mechanistic insights from PCSK9 LOF mutations with a particular focus on data from the Copenhagen studies, were discussed by Professor Anne Tybjaerg-Hansen, Rigshospitalet, Copenhagen University Hospital, and University of Copenhagen, Denmark. Seminal studies showed that carriage of LOF mutations was associated reduction in LDL cholesterol…
read more »Posted on 30 September 2014 |
Posted by Anne Tybjaerg-Hansen | Posted in Article Archive,
Webcasts,
Inaugural Closed Scientific Expert Meeting of the Editorial Board,
Inaugural Closed Expert Meeting of the Editorial Board 2014
